Stocks Health care RDGL
OTC · Health careVivos Inc (RDGL)
Vivos Inc brought in $99.1K of revenue over the twelve months to June 30, 2026, up 91.5% from a year earlier. It posted a net loss of $3.6M. In fiscal 2025 capital spending exceeded operating cash flow by $2.2M. At June 30, 2026 it held $2.3M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 12, 2026.
Watch RDGL in 60 secondsWhat Vivos Inc does
Vivos Inc is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on OTC under the ticker RDGL.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $68.4K | -$3.1M | -$0.01 | -$2.2M |
| 2024 | $28K | -$2.9M | -$0.01 | n/a |
| 2023 | $19.5K | -$2.9M | -$0.01 | n/a |
| 2022 | $36.5K | -$2.5M | -$0.01 | n/a |
| 2021 | $14.9K | -$2.5M | -$0.01 | n/a |
| 2020 | $7K | -$957K | $0.00 | n/a |
Full financial statements: income, balance sheet and cash flow
Where RDGL ranks in Health care
Latest SEC filings
What Vivos Inc has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 12, 2026Quarterly report 10-Q · period to June 30, 2026Revenue rose 143% to $36.4K versus the same quarter last year; diluted EPS $0.00 versus $0.00.
- May 14, 2026Quarterly report 10-Q · period to March 31, 2026Revenue rose 35% to $36.1K versus the same quarter last year; diluted EPS $0.00 versus $0.00.
- March 31, 2026Annual report 10-K · period to December 31, 2025Revenue rose 144% to $68.4K versus the prior year; diluted EPS -$0.01 versus -$0.01.
- March 5, 2026Form QUALIF filing QUALIF
- March 4, 2026Form 1-A/A filing 1-A/A
- February 17, 2026Form 1-A filing 1-A
- November 12, 2025Quarterly report 10-Q · period to September 30, 2025Revenue fell 62% to $1.9K versus the same quarter last year; diluted EPS $0.00 versus $0.00.
- September 24, 2025
- September 22, 2025
- September 18, 2025Other event 8-K
Insider trades
What the people running Vivos Inc did with its shares, from the Form 4 filings they must send the SEC within two business days.
Insiders bought $37.6K worth of shares on the open market in the last 90 days and sold none.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| September 16, 2026 | Weeks Brad AllanPresident | Bought | 25,550 | $1.2K |
| August 10, 2026 | Korenko Michael KCEO AND PRESIDENT, Director | Bought | 150,000 | $8K |
| August 10, 2026 | Weeks Brad AllanPresident | Bought | 50,000 | $2.7K |
| July 22, 2026 | Weeks Brad AllanPresident | Bought | 32,000 | $1.6K |
| July 21, 2026 | Weeks Brad AllanPresident | Bought | 60,000 | $3K |
| July 15, 2026 | Korenko Michael KCEO AND PRESIDENT, Director | Bought | 200,000 | $11.4K |
| July 10, 2026 | Weeks Brad AllanPresident | Bought | 12,000 | $960 |
| July 10, 2026 | Weeks Brad AllanPresident | Bought | 12,000 | $960 |
| July 9, 2026 | Weeks Brad AllanPresident | Bought | 48,000 | $3.8K |
| July 9, 2026 | Weeks Brad AllanPresident | Bought | 48,000 | $3.8K |
| June 30, 2026 | Weeks Brad AllanPresident | Received as pay | 147,159 | - |
| May 11, 2026 | Korenko Michael KCEO AND PRESIDENT, Director | Bought | 150,000 | $9.3K |
| March 31, 2026 | Weeks Brad AllanPresident | Received as pay | 100,111 | - |
Who owns RDGL
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
Largest institutional holders
Insiders
2 insiders reported holding 12,982,294 shares in total, about $595.9K at the last price.
| Holder | Shares |
|---|---|
| Korenko Michael KCEO AND PRESIDENT, Director | 11,435,090 |
| Weeks Brad AllanPresident | 1,547,204 |
Questions about RDGL
What does Vivos Inc do?
Vivos Inc is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on OTC under the ticker RDGL.
Is Vivos Inc profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $3.6M on revenue of $99.1K.
How much revenue does Vivos Inc make?
Over the twelve months to June 30, 2026 Vivos Inc reported revenue of $99.1K. That is 91.5% more than a year earlier.
When did Vivos Inc last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 12, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the insider trade from September 16, 2026.
Similar companies
Compare RDGL with
Follow RDGL
Get an email when Vivos Inc files with the SEC: results, executive changes, material agreements and annual reports.
Follow RDGL: get an email when it filesWhere the numbers come from
Financial figures are the values Vivos Inc tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.